JAK-IN-35

JAK-IN-35

• CAS Number: 936091-15-5
• UNSPSC Description: JAK-IN-35 (compound TG46) is a JAK2 inhibitor that canb be used in cancer research[1].
• Target Antigen: JAK
• Type: Reference compound
• Related Pathways: Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt
• Applications: Cancer-Kinase/protease
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/jak-in-35.html
• Solubility: 10 mM in DMSO
• Smiles: O=S(C1=CC=CC(NC2=NC(NC3=CC=C(CN4CCOCC4)C=C3)=NC=C2C)=C1)(NC(C)(C)C)=O
• Molecular Weight: 510.65
• References & Citations: [1]Wenge Zhu, et al. Combination therapy for treating cancer. Patent WO2018187485A1.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported